The global BCG vaccine market size was valued at USD 98.15 million in 2022 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.17% from 2023 to 2030. This can be attributed to the rising prevalence of tuberculosis, technological advancement in vaccine R&D, and increa... Read More »
December 2023The global dipeptide peptidase 4 inhibitors market size was valued at USD 11.3 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.8% from 2024 to 2030. The market is driven by factors such as the increasing prevalence of diabetes, a growing number of dia... Read More »
December 2023The global complex regional pain syndrome market size was valued at USD 103.5 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 2.8% from 2023 to 2030. Complex regional pain syndrome (CRPS) is a type of persistent pain condition that commonly impacts one ... Read More »
December 2023The global microneedle flu vaccine market size was valued at USD 1.4 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.20% from 2023 to 2030.The microneedle flu vaccine market is anticipated to experience significant growth due to the rising worldwide ... Read More »
December 2023The global pseudomonas aeruginosa infection treatment market size was valued at USD 2.13 billion in 2022 and is expected to grow at a CAGR of 5.03% from 2023 to 2030. The pseudomonas aeruginosa infection treatment market is driven by the pathogen's high antibiotic resistance, necessitati... Read More »
December 2023The global primary biliary cholangitis therapeutics market size was valued at USD 686.5 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030. Primary biliary cholangitis (PBC) is an autoimmune liver disease that affects small bile duct... Read More »
December 2023The global hairy cell leukemia market size was valued at USD 88.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.06% from 2023 to 2030.The increasing incidence of hairy cell leukemia, particularly in older adults, is a fundamental driver that drives ... Read More »
December 2023The global retinoblastoma treatment market size was valued at USD 2.42 billion in 2022 and is expected to grow at a CAGR of 4.26% over the forecast period. This is attributed to the rising incidence of retinoblastoma, growing advancements in medical technology, and increasing number of r... Read More »
December 2023The global scopolamine market size was valued at USD 385 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.75% from 2023 to 2030. The rising incidence of motion sickness and the increasing population of geriatrics are anticipated to boost the demand f... Read More »
December 2023The global non hodgkin lymphoma therapeutics market size was valued at USD 9.14 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.95% from 2023 to 2030. The non hodgkin lymphoma therapeutics market is anticipated to experience significant... Read More »
December 2023The global tourette syndrome treatment market size was valued at USD 2.07 billion in 2022 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.96 % from 2023 to 2030. The ongoing research advancements, increased awareness and advocacy efforts, government initiatives, inno... Read More »
December 2023The global endometrial cancer market size was valued at USD 25.10 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.69% from 2023 to 2030. This is attributed to the rising incidence of endometrial cancer, growing advancements in early detection & di... Read More »
December 2023The global malignant glioma therapeutics market size was valued at USD 1.40 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.26% from 2023 to 2030. This is attributed to the rising incidence of brain tumor, the increasing number of research & deve... Read More »
December 2023The global pigmentation disorders treatment market size was valued at USD 6.8 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.87% from 2023 to 2030. The pigmentation disorders treatment market is expected to experience growth due to the increasing pre... Read More »
December 2023The global critical limb ischemia treatment market size was valued at USD 4.90 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.12% from 2023 to 2030.The aging population continues to grow, and the prevalence of critical limb ischemia, a condition char... Read More »
December 2023The global DNA repair drugs market size was valued at USD 5.9 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 14.34% from 2023 to 2030. The DNA recovery drugs market is driven by the increasing prevalence of cancer, with a rising number of new cancer ca... Read More »
December 2023The global anthrax treatment market size was valued at USD 361.4 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.95% from 2023 to 2030. The anthrax treatment market is anticipated to witness significant growth due to the rising number of novel and inn... Read More »
December 2023The global alpha-glucosidase inhibitors market size was estimated at USD 4.67 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 2.70% from 2023 to 2030. The market growth is fueled by the increasing prevalence of diabetes, growing demand for safe diabe... Read More »
December 2023The global sickle cell disease treatment market size was valued at USD 2.8 billion in 2023 and is projected to grow from USD 4.0 billion in 2026 to USD 7.4 billion by 2030, at a CAGR of 15.2% from 2024 to 2030. The market in North America dominated with a revenue share of 37.9% in 2023. ... Read More »
December 2023The global antidote market size was valued at USD 2.2 billion in 2023 and is projected to grow from USD 2.7 billion in 2026 to USD 3.6 billion by 2030, at a CAGR of 7.6% from 2024 to 2030. The market in North America dominated with a revenue share of 33.6% in 2023. Increasing number... Read More »
December 2023